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CHAPTER 1. GENERAL INTRODUCTION 
Inflammatory central nervous system (CNS) disease in the canine can be 
associated with a number of infectious and non-infectious etiologies that include 
canine distemper virus (CDV), granulomatous meningoencephalomyelitis (GME), 
lymphoma, the protozoa! agents, Toxoplasma gondii and Neospora caninum, and 
rickettsial diseases, Ehrlichia canis (ehrlichiosis) and Rickettsia rickettsii (Rocky 
Mountain Spotted Fever, (RMSF)). It is currently unknown if the diseases we 
diagnose as GME are a single disease syndrome or a group of diseases. Diagnosis 
of these CNS diseases is most commonly accomplished through cerebrospinal fluid 
(CSF) analysis and titers to differentiate infectious agents. Each disorder is 
characterized in the CSF by primarily a mononuclear pleocytosis consisting of 
lymphocytes, macrophages, monocytoid cells, and lesser numbers of neutrophils. 
The increase in mononuclear cell counts, primarily lymphocytes, is similar in these 
diseases. 1-3• 5-11 Lymphoblast and prolymphocyte-like cells have been noted in CSF 
from canine distemper cases and malignant lymphoma. Total protein content is 
usually elevated. Measuring titers for infectious diseases may be complicated by 
peripheral blood and serum contamination of the samples. In many cases, the 
cellular composition of the CSF associated with these diseases is quite similar, 
making antemortem diagnosis, treatment and prognostication difficult. We 
hypothesize that diseases producing mononuclear pleocytosis are distinct and can 
be distinguished from each· other by using immunohistochemical typing of 
lymphocytes and monocyte/macrophages. This retrospective study will correlate 
immunohistochemical staining of T and B lymphocytes and 
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monocytes/macrophages in CNS tissues to postmortem disease diagnosis using 
light microscopy.4·12 The objectives of this study are to help differentiate these 
inflammatory, infectious and neoplastic diseases immunohistochemically and to aid 
in treatment protocols and prognostication for each disease. This research will aid 
investigations into the etiology, primary cell type and possible mechanisms of GME. 
Also, some of these canine diseases may serve as a model for other human CNS 
disorders such as multiple sclerosis and Lyme neuroborreliosis where cytologic 
findings are similar to the inflammatory diseases discussed above. 
Thesis Organization 
This thesis contains four chapters: Chapter 1, A General Introduction which 
outlines the problem being researched and the objectives of the study, and the 
thesis organization; Chapter 2, a separate Literature Review of the previous work 
on the subject to be submitted to the Journal of Veterinary Internal Medicine; 
Chapter 3, a manuscript that is being submitted to the journal "Veterinary 
Pathology"; and Chapter 4, a final chapter including General Conclusions. 
Chapter 1 - The first chapter consists of a general introduction to the problem of 
differentiating CNS inflammatory and infectious disease in the canine and how 
immunohistochemistry plays a role in the differentiation of these disorders. Included 
also is the thesis organization. 
Chapter 2 - The second chapter is the literature review that details the many uses of 
immunohistochemistry, the different methods used and their use to differentiate 
those canine CNS inflammatory and infectious disorders that produce a 
mononuclear pleocytosis. These diseases, their pathophysiology, histologic and 
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immunohistochemical characteristics are discussed. This manuscript is prepared for 
submission to the Joumal of Veterinary lntemal Medicine. 
Chapter 3 - In this manuscript, we hypothesize that canine central nervous system 
(CNS) inflammatory and infectious diseases producing mononuclear pleocytosis can 
be differentiated using immunohistochemistry. Disease categories include 
granulomatous meningoencephalomyelitis (GME), canine distemper virus, 
toxoplasmosis, neosporosis, malignant spinal cord lymphoma, and unclassified CNS 
inflammation. lmmunohistochemical staining (CD3, lysozyme, anti-canine lgG, M, 
A) was performed. Results were compared and contrasted to the literature. 
Considerations for future research include the use of immunohistochemical methods 
for CSF samples to aid in antemortem diagnosis of these diseases. This manuscript 
is prepared for submission to the journal, Veterinary Pathology. 
Chapter 4 - Includes a general discussion of the problems in differentiating canine 
CNS inflammatory and infectious diseases that produce mononuclear pleocytosis 
and recommendations for future research into the role of immunohistochemistry in 
antemortem diagnosis of these diseases. 
References will be presented at the end of each chapter . Figures and tables with 
legends will be presented at the end of Chapters 2 and 3. 
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CHAPTER 2. LITERATURE REVIEW - THE USE OF IMMUNOHISTOCHEMICAL 
TECHNIQUES TO DIFFERENTIATE CANINE CNS INFLAMMATORY AND 
INFECTIOUS DISEASES PRODUCING MONONUCLEAR PLEOCYTOSIS 
A paper to be submitted to the Journal of Veterinary Internal Medicine 
Karen L. Kline, Claire Andreasen 
Abstract 
Central nervous system (CNS) inflammatory diseases are common in 
the canine population, and the collection of cerebrospinal fluid (CSF) is used to 
correlate cytologic findings with disease etiology. The most common of these 
diseases is grariulomatous meningoencephalomyelitis (GME). The etiology of GME 
is still unknown, although immune-mediated, neoplastic and infectious 
pathogeneses are proposed. Differentiation of GME from other inflammatory and 
neoplastic CNS diseases, including canine distemper virus (CDV), encephalitis, 
rickettsial (Ehrlichia canis and Rickettsia rickettsi1) meningitis, and protozoal 
(Neospora caninum and Toxoplasma gondit) CNS disease can be difficult. Clinical 
neurologic signs may be quite similar among cases. Each disorder is characterized 
by a primarily mononuclear CSF pleocytosis consisting of lymphocytes, 
macrophages, and lesser numbers of neutrophils. lmmunohistochemical techniques 
have been used in some of these diseases (GME and CDV) to identify B and T cell 
and macrophage subpopulations and to correlate cell population to disease 
diagnosis. This review focuses on a discussion of canine CNS inflammatory and 
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infectious diseases, proposed pathogeneses, neurolcgic signs, diagnostic findings, 
histopathologic lesions, and how current immunohistochemical techniques may aid 
in their characterization and differentiation. 
Key words: Granulomatous meningoencephalomyelitis; canine distemper; protozoa! 
infection , rickettsial infection 
Discussion 
Inflammatory and infectious diseases of the CNS in the canine have been 
discussed in the literature for a number of years. Examples of these include 
granulomatous meningoencephalomyelitis (GME), pug encephalitis, and necrotizing 
meningitis of the Yorkshire terrier and Maltese breeds. 1-14 Infectious agents include 
canine distemper virus, the rickettsial agents Ehr/ichia canis and Rickettsia rickettsii 
(RMSF), and protozoa! agents (Toxoplasma gondii and Neospora caninum). Clinical 
neurologic signs can vary as focal or multifocal, with all portions of the central 
nervous system being affected. Some of these diseases also manifest more 
systemic signs, especially infectious agents such as rickettsial agents. 
Diagnostic evaluation of dogs suspected to have inflammatory or infectious 
CNS disease relies primarily on patient signalment, an accurate history, recognition 
of abnormal clin ical and neurologic signs, minimum data base results, and ancillary 
testing, such as CSF analysis and diagnostic imaging such as CT scan or MRI. The 
antemortem differentiation based upon CSF analysis, can be quite difficult, in many 
cases, since the CSF contains a mixed population of inflammatory cells that are 
primarily mononuclear with lesser numbers of neutrophils 15-17 (Fig 1 ). In addition, 
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CSF findings can vary with timing of sampling and chronicity of the disease process. 
Because of this, differentiation of these diseases can be challenging , especially, 
since treatment protocols used for one disease may not be the best for another. 
The purpose of this review is to discuss CNS diseases that produce mononuclear 
pleocytosis in regard to clinical signs, proposed etiology, diagnosis, and 
histopathologic findings. Also, immunohistochemistry is being used to help 
differentiate these diseases that produce a mononuclear pleocytosis. Diseases 
discussed are granulomatous meningoencephalomyelitis (GME), canine distemper 
virus encephalitis, toxoplasmosis, neosporosis, ehrlichiosis and Rocky Mountain 
Spotted Fever. 
lmmunohistochemistry 
In order to acquaint the reader with the potential use of immunohistochemical 
staining in the diagnosis of CNS diseases, a brief description will be given. 
lmmunohistochemical staining is the detection of antigens in tissue sections and 
other cytologic preparations by using labeled specific antibodies so that sites of 
attachment become visible microscopically. lmmunostaining relies on the ability of 
the primary antibody to bind to the antigens in the tissue specimen. 18 Uses include 
diagnosis of diseases associated with autoantibodies, neoplasia, immune complex 
deposition, and detection of infectious microorganisms. Multiple techniques and 
methods used in immunohistochemistry have been described. 18-23 
One of the most commonly used techniques is the indirect immunostaining 
method in which an enzyme-conjugated anti-immunoglobulin second antibody is 
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used to detect binding of the primarily antibody to a paraffinized tissue section 
(Fig . 2). The advantage to this technique is enhanced sensitivity of antigen 
detection (immunoreactivity) because several secondary antibodies will bind to each 
primary antibody and thus intensify the visible color produced via a chromagen. 
Also, indirect stains do not require conjugation of each primary antisera. An even 
more sensitive indirect immunoenzyme technique that amplifies the 
immunoreactivity is the avidin-biotin complex (ABC) method. Briefly, this technique 
relies upon the affinity of the B-vitamin, biotin, for avid in, an egg-white glycoprotein. 
Antigens bind an unlabelled primary antibody followed by a secondary antibody to 
an immunoglobulin labeled with biotin. After the secondary antibody is applied, the 
tissue is exposed to preformed avidin and biotin complexes and these complexes 
bind to tissue-associated biotinylated secondary antibody. The biotin molecules are 
labeled with an enzyme substrate (usually peroxidase) and a color reaction product 
forms after application of a chromagen, at the site of antibody-enzyme complex 
binding. This is visualized using light microscopy. The amplification obtained from 
this staining technique is helpful in detecting scarce antigens or antigens that have 
been affected by formalin fixation . Examples of these include stains for the T cell 
antigens [CD3, CD4 and CD8], lysozyme, (macrophage/histocyte antigens), and B 
cells (anti-canine lgG, A and M). · 
In summary, immunohistochemical techniques can be helpful in detection of 
cellular antigens. These antigens can be detected not only on neoplastic and 
infectious cells themselves, but can be normal constituents of white blood cells, glial 
cells and other neural cells found in the CNS in healthy and affected animals. Thus, 
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the use of immunohistochemical staining has been described in the identification 
and characterization of mononuclear cell populations associated with such 
inflammatory diseases of the CNS as GME and canine distemper virus. 24•32 It is 
hoped that the characterization of these different mononuclear subpopulations, 
specifically in GME, will aid in discovering the true pathogenesis and proper 
treatment of these disorders, as well as learning about a possible animal (canine) 
model for human immune-linked neurologic diseases such as multiple sclerosis. 3·34 
CNS Diseases 
Granulomatous meningoencephalomyelitis (GME) is an inflammatory disease 
of the central nervous system that occurs in the canine (Table 1 ). This syndrome 
has been discussed for years in the veterinary literature and its underlying etiology 
has yet to be determined.1·3•8·9·11 ·13·32·35 Theories include an infectious cause (viral or 
bacterial) , an immune-mediated phenomenon that may or may not be triggered by 
an infectious agent, or an underlying neoplastic etiology. In older literature, some 
cases of GME were referred to as "neoplastic reticulosis". To date, none of these 
theories has been proven, although an underlying immune pathophysiology is 
suspected. 35 Signalment of these dogs is variable, but the disease is reported to 
affect young to middle aged toy breeds with a greater female than male gender 
predilection. Most dogs are otherwise healthy, have current vaccinations, 
unremarkable physical examinations, and no known toxin exposure. Neurological 
clinical signs reflect the focal or multifocal nature of the CNS lesions. Signs can be 
acute or chronically progressive, and have been described as focal, disseminated 
and/or ocular. 1•2·8·11·13·35 The ocular form is most commonly observed with the 
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disseminated (multifocal) form. The GME focal form mimics a focal mass that can 
cause forebrain (cerebral) , brain stem or spinal cord signs. Forebrain clinical signs 
can include seizures, circl ing, behavior changes, proprioceptive ataxia, and 
hemiparesis. Neurologic examination shows contralateral partial cranial nerve 
deficits, conscious proprioceptive loss, vision loss, hemiparesis and hemisensory 
loss. Focal brainstem disease signs vary according to lesion location , but can 
include consciousness changes, central vestibular signs, such as ipsilateral or 
contralateral head tilt, complete ipsilateral cranial nerve deficits, hemiparesis, and 
conscious proprioceptive loss. If the medulla (myelencephalon) is involved, 
ventilatory changes and cardiac arrhythmias may occur. If pathologic nystagmus is 
present, it may be especially pronounced with a change in body position. Focal 
cerebellar signs may include intention tremor, dysmetria and ipsilateral menace loss. 
The cervical spinal cord is most often affected with focal GME, and signs can range 
from neck pain to concurrent conscious proprioceptive loss, tetraparesis/plegia, and 
loss of conscious pain perception. Focal GME has been described as slowly 
progressive, much like a focal mass, and is due to a focal whorling accumulation of 
mononuclear cells in the brain parenchyma. 
Disseminated GME has been described as more acute and insidious in onset 
and having a poorer prognosis. Neurologic signs, as the name implies, can be 
multifocal with a combination of forebrain , brainstem, central vestibular, and spinal 
cord abnormalities. Concurrent ocular changes, include optic disk bulging and optic 
neuritis, can be observed in any form of GME. 
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Even though toy breeds are commonly affected in GME, the literature cites 
other dog breed-related granulomatous or mononuclear meningitis and 
encephalitis .4·5·6·10·13·35 Breeds include Yorkshire terriers, Maltese, and pugs (Table 
1 ). Clinical neurologic signs observed in these breeds are similar to other dogs 
diagnosed with GME and it is unknown whether these are merely subsets of the 
same disease process or separate entities. Some speculate there is evidence of a 
predisposing genetic factor. 35 A breed-specific tissue antigen could act as a · 
receptor for an unknown virus or may have a breed-specific composition of the 
immune response genes that leads to an abberant immunologic reaction toward a 
known pathogen.35 The only difference in these diseases has been the variability in 
histopathologic lesions observed. 
The diagnostic test of choice for GME, and the pug, Yorkshire terrier and 
Maltese encephalitides is CSF analysis, obtained either from the cisterna magna or 
lumbar subarachnoid space. CSF analysis in these dogs contains a mixed 
population of inflammatory cells that are primarily mononuclear 
(lymphocytes/macrophages) with equal or lesser numbers of neutrophils (Fig. 3). 
CSF total protein can be normal to extremely elevated, and protein content and 
inflammatory cell numbers can vary due to the focal or disseminated lesions. In a 
few cases, CSF analysis can be within normal limits.9·15 
Histopathologic findings in GME have been described. 1·2·3·8·9·11·35 Lesions can 
be focal or multifocal and consist of mild to severe perivascular mononuclear 
infiltrates comprised of lymphocytes, plasma cells, and macrophages involving the 
brain parenchyma and/or meninges (Fig 4). This can be observed alone or in 
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combination with mild to severe granulomatous infiltrates composed primarily of 
lymphocytes, plasma cells, macrophages and lesser numbers of neutrophils either 
in the brain parenchyma or meninges (Fig. 5). One report cites the formation of 
eccentrically situated nodular foci of macrophages within perivascular infiltrates as a 
characteristic finding . 35 
The histopathologic features of pug encephalitis, and necrotizing encephalitis 
· of Maltese dogs are similar, and are different from findings in other known canine 
CNS infections.4·5·13·35 The predominantly' mononuclear inflammation is suggestive 
of a viral cause, but none has been isolated. In both cases, there is a predilection 
for the cerebrum. A disseminated necrotizing meningitis, choroiditis and 
encephalitis is present in the cerebrum, with perivascular and meningeal infiltrates 
composed of lymphocytes, plasma cells and macrophages invading the 
parenchyma. Extensive focal subpial and subventricular lesions may extend deep 
into the parenchyma with severe microglial malformation and tissue destruction 
leading to cerebrocortical necrosis. Cerebral white matter can be affected, as well, 
with perivascular infiltrates and gliosis. Leukomalacia with liquefaction and 
cavitation also is observed. 
The histopathologic lesions observed in Yorkshire terrier encephalitis are 
quite different from those in the pug and Maltese breeds. 13·35 Again, a viral cause is 
suspected. The lesions consist of a malacic center surrounded by blood vessels 
with perivascular infiltrates of cells, involve the cerebral cortex and brainstem white 
matter, and are multifocal and destructive. Older lesions are cystic with intense 
astrocytic sclerosis. No causative agents have been observed microscopically nor 
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detected immunohistochemically in cases of GME and the encephalidites of the 
pug , Yorkshire terrier, and Maltese breeds. 
lmmunohistochemical (IHC) staining of the brain tissue classified as GME 
has been performed to characterize the subpopulation of lymphocytes, 
macrophages, and other inflammatory cells.24·28 The subpopulations of these 
immunohistochemically reactive cells in dogs with GME have been described in the 
literature. In cases of GME, IHC for canine distemper, toxoplasmosis and 
neosporosis has been negative. In one paper, the predominant cell populations 
observed in the brains of dogs with GME were CD3 antigen positive T cells with 
lesser numbers of lgM and lgG B cells24 (Figs.6,7). The majority of macrophages 
have both lysozyme and DH82 antigen, while MHC II antigen major 
histocompatibility complex II antigen (MHC II), was found in all inflammatory cells, 
pericytes and microglia within and associated with lesions. In the above study of 11 
dogs, the pathogenesis of GME is theorized to be a T-cell mediated delayed-type 
hypersensitivity of an organ specific (brain) auto-immune disease.24 More studies 
are needed to substantiate these results. In another study of 17 dogs, lgA, lgG and 
lgM B cells were found to be numerous, although the comparative T cell population 
was not studied.28 The etiology of GME is still unknown, but further investigation 
using immunohistochemical techniques may lead to a more thorough understanding 
of the underlying etiologies and, thus, more specific and efficacious treatment 
options. To date, little has been done immunohistochemically to characterize the 
cellular infiltrates in pug, Maltese, and Yorkshire terrier encephalitis. 
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Canine distemper virus (CDV) is a contagious viral disease of the family 
Paramyxoviridae, genus Morbillivirus (Table 1). This virus is infectious for a number 
of carnivores including dogs, coyotes, wolves, as well as ferrets, minks, skunks, and 
weasels. Tissue tropism varies among strains and neural tissue is commonly 
affected. Viral transmission is more common through the aerosol route. 36 Factors 
influencing virulence include viral strain, age, breed, and immunocompetence of the 
dog. Pathogenesis is well known 12·13•35•39 and 7% of dogs that develop serum virus-
neutralizing antibody titers (>1:100) within 9 to 14 days of exposure develop 
neurologic signs 6 to 9 weeks after initial exposure despite adequate neutralizing 
antibody titers. 36 Systemic clinical signs are non-specific and include fever, 
diarrhea, cough, nasal discharge, decreased appetite, and weight loss. CDV has a 
tropism for neural tissue, particularly the white matter of the CNS with a few 
exceptions. Antiviral antibody and immune complex deposition may facilitate 
spread of the virus throughout the CNS vascular endothelium. Forebrain, 
brainstem, cerebellum and spinal cord may be affected and this is dependent upon 
the animal's immunocompetence, age and concurrent disease. Neurologic signs 
commonly follow 2 to 3 weeks after the initial systemic signs and are age-
dependent. Presentation varies from forebrain signs including generalized to 
"chewing gum type" seizures, behavior changes, and blindness to central vestibular 
signs, to spinal cord signs such as proprioceptive ataxia, tetra or para-paresis/plegia 
and generalized hyperesthesia. Myoclonus also has been described as a 
pathognomonic feature of CDV. One retrospective study of 38 dogs on necropsy 
categorized them as having either polioencephalomyelopathy (PEM), 
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leukoencephalomyelopathy (LEM) or equal PEM and LEM. 12 Dogs with PEM were 
immature and had an acute onset of seizures (within 12 days), while dogs with 
PEM/LEM or LEM were mature with a longer duration (mean 23 days) of gait and 
central vestibular dysfunction. Other studies have classified CDV as having a 
definite temporal relationship to clinical signs and histopathologic findings. 
Diagnosis of neurologic CDV is dependent upon history, vaccination status, 
and signalment of the dog, as well as, findings on physical and neurologic 
examination. Other key diagnostic findings are chorioretinitis (either active or 
inactive), enamel hypoplasia, and a predominantly lymphocytic mononuclear 
pleocytosis on CSF analysis, with or without an elevated CSF total protein. An 
elevated CSF CDV Ab titer (lgG, lgM), especially in a dog with a questionable 
vaccination history, is also helpful. Inclusion bodies in blood cells and/or 
conjunctiva! scrapings may or may not be seen.12·36·38 
Histopathologic lesions of CDV vary with disease process and range from 
mild (acute stage) to severe (chronic stage). The primary lesions, especially in the 
more subacute to chronic stages, are moderate to severe mononuclear perivascular 
infiltrates of mononuclear cells, microglial proliferation, mononuclear pial and 
arachnoid meningial infiltrates, and intranuclear and/or intracytoplasmic inclusion 
bodies. In the acute phase of infection, demyelination may be the only lesion 
observed with minimal to no mononuclear cellular infiltration. This may be 
accompanied by gliosis, astrocytosis, vascular endothelial cell hypertrophy, and mild 
macrophage infiltration. Demyelination has been described as most prominent in 
the cerebellum, cerebellar peduncles, optic nerves, optic tracts, medullary velum 
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and spinal cord. It is theorized that minimal inflammatory changes observed in 
acute CDV infection may be due to the physiologic immaturity of the puppy's 
immune system.12•17·36·38 The demyelination observed in early lesions is thought to 
be direct virus-induced oligodendroglial damage.40 
In mature dogs, more chronic multifocal encephalitis or encephalomyelitis 
may occur and may not be preceded by systemic signs of disease. As the disease 
becomes more subacute to chronic, mononuclear perivascular infiltrates and glial 
lesions become more severe and prominent. Subacute to chronic CDV infections 
have been termed "old dog encephalitis". These dogs usually are older and have 
primarily forebrain signs such as seizures, blindness, and behavior changes, such 
as circling and head pressing. Histopathologic changes consist of diffuse sclerosis, 
increased numbers of astrocytes and microglial proliferation, and cerebrocortical 
neuronal degeneration. It has been theorized that CDV sequesters itself in the older 
dog's CNS, even in the face of an effective immune response, and induces the 
secretion of inflammatory mediators by perivascular macrophages. Such mediators 
include 0 2 radicals, and cytokines, which may lead to further demyelination and 
inflammation. This response has been called the "bystander mechanism".26•35·37•39·40-
42 In the sclerotic stage, inclusion bodies are rarely found. 
Post-vaccinal CDV infection has been reported and can occur 1 to 2 weeks 
post-vaccination with a modified-live, attenuated vaccine. Seizures, aimless circling , 
blindness and aggression can be seen. Histopathologic lesions affect more gray 
matter, than white matter and consist of diffuse malacia of the ventral pontine 
region, neuronal inclusions, and mononuclear perivascular infiltrates.43.44 
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The immunohistochemical characterization of CDV has demonstrated there is 
a definite temporal association between onset of infection, type of cell , and lesion 
produced (Fig. 8) .22·25-27·29-31 .4°.44-49 As stated previously, lesions can be acute (non-
inflammatory) , subacute (inflammatory) chronic, or sclerosing. In the acute stage, 
there tends to be a diffuse up-regulation of T cells throughout the CNS and T cell · 
invasion in early demyelinating lesions, even though there is minimal inflammation. 
T cell invasion has been correlated with sites of viral replication26 and coincides with 
the demonstration of an early immune response against the nucleocapsid protein of 
CDV. Microglial cell activation is theorized to elicit T cell migration to the CNS by 
secretion of cytokines, namely IL-8. In the more subacute to chronic stages of the 
disease, the perivascular infiltrates were composed of 60% CD3+ lymphocytes, and 
40% B cells.26 In another study, the numbers of lgG, lgA, and lgM B cells were 
variable in CDV dogs with lgG and lgA increased with chronic to sclerotic lesions 
and mononuclear perivascular infiltrates.27 Another study recognized B cells in 
chronic lesions and their importance for intrathecal antibody production.71 In chronic 
CDV lesions, MHC II was markedly up-regulated throughout the white matter.5° CDV 
immunochemistry has been used to identify CDV antigen, and in one study, CDV 
antigen was identified in brain tissue, haired skin, nasal mucosa and footpad 
epithelium.22 The immunohistochemical detection of CDV antigen is more 
prominent within astrocytes in acute stages of disease than in the chronic 
stages_ 14.2s,21,29 
The protozoa! diseases caused by Toxoplasma gondii and Neospora 
caninum have been recognized as causes of central and peripheral nervous system 
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disease in the canine.13·51-57 Areas of the affected nervous system can include the 
forebrain, brainstem, cerebellum, spinal cord , nerve roots, peripheral nerve and 
muscle, alone or in combination (Table 1 ). Affected dogs can be any age or gender. 
The pathogenesis of these 2 diseases is dependent upon the host's 
immunocompetence and presence of current disease. Clinical signs are similar and 
can involve multiple organ systems, in addition to the nervous system. Systemic 
signs include fever, icterus, cough, dyspnea, gastroenteritis, and sudden death. 
Neurologic clinical signs are dependent upon the area of the nervous system 
affected, can be focal or disseminated (multifocal), and can include seizures, 
circling, behavior changes, central vestibular signs, spinal ataxia, 
hemiparesis/plegia, and generalized or focal hyperesthesia. Lower motor neuron 
signs and muscle atrophy, muscle pain and contracture, and hyperextension of the 
hind limb musculature also can be observed . 
Diagnostic evaluation of a dog suspected of having neurologic protozoa! 
disease includes signalment, thorough history, documentation of concurrent 
disease(s), physical and neurologic examinations, ophthalmic exams, CBC and 
blood chemistry, diagnostic imaging, and CSF analysis. CSF analysis can be quite 
variable, but commonly consists of a pleocytosis with a predominance of 
mononuclear cells, with lesser numbers of neutrophils and, on occasion, 
eosinophils. Total protein can be mildly to severely elevated . Etiologic agents are 
rarely seen in CSF cytology. Serologic titers in serum or CSF for protozoa! agents 
are often negative. 
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The key histologic feature of CSF protozoa! disease is necrosis followed by 
inflammation in multiple organs including the brain, spinal cord , and muscle. 
Nonsuppurative necrotizing encephalomyelitis, myocarditis, hepatitis and myositis 
have been reported. 54 Encephalomyelitis can be characterized by 
polyradiculonuritis, ganglionitis, axonal degeneration, perivascular infiltrates, 
necrosis, granuloma formation, and glial nodule formation. Both white and gray . 
matter can be affected and organisms (tachyzoites) may be seen in areas of 
necrosis. 
lmmunohistochemical differentiation of Toxoplasma gondii from Neospora 
caninum using an indirect fluorescent antibody test and perioxidase-antiperoxidase 
techniques have been described.52·57 This can be helpful in cases of non-specific 
meningoencephalitis where no organisms are found. Currently, there are no 
publications of immunohistochemical characterization of inflammatory cell 
populations found in the brains of dogs infected with these protozoa! agents (Fig. 9). 
The rickettsial agents Ehrlichia canis, the ehrlichial granulocytic strains, and 
Rickettsia rickettsi (the causative agent of Rocky Mountain Spotted Fever) have 
been associated with central nervous system signs in the canine (Table 1). The 
pathogenesis of these agents has been described and the common vector is the 
tick_ 13,32,ss-s1 
Clinical signs are multisystemic with acute or chronic progression. Fever, 
depression, weight loss, polyarthropathies, and bleeding tendencies, due to 
thrombocytopenia, have been described along with other signs of multi-organ 
involvement. The neurologic signs observed with both diseases are similar and can 
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affect any portion of the nervous system (brain, spinal cord , or neuromuscular). 
Signs can be focal or multifocal and are primarily due to meningitis from 
inflammation and/or petechiation or hemorrhage, and include seizures, stupor, 
ataxia, tetra, para or hemiparesis, central vestibular signs, upper or lower motor 
neuron dysfunction, tremor, dysmetria, generalized or localized hyperesthesia and 
polymyositis. 
Diagnosis of neurologic disease caused by E. canis or R. rickettsii is based 
upon history, hematologic results, joint fluid cytology, titers, and concurrent signs of 
non-neurological systemic disease. CSF analysis differs slightly between these 
agents. E. canis can cause a primarily mild to moderate mononuclear inflammatory 
meningitis comprised of lymphocytes, plasma cells and macrophages; total protein 
may be elevated. Organisms (morulae) may or may not be seen. The CSF analysis 
. observed in RMSF is primarily a mixed pleocytosis with higher numbers of 
neutrophils admixed with mononuclear cells and an occasional eosinophil. Total 
protein may or may not be elevated, and organisms usually are not seen. Titers in 
CSF have been found to be equivocal depending on the acute or chronic nature of 
the disease and the severity of breakdown in the blood brain barrier due to 
inflammation. 60 
Histopathologic lesions observed with ehrlichial infections range from 
multifocal nonsuppurative meningoencephalitis involving the cerebrum, brainstem, 
(ventrally and around the periventricular gray and white matter) spinal cord , and 
rarely the cerebellum. Concurrent ocular lesions also are described.62 A 
lymphoplasmacytic perivascular meningeal infiltrate may be observed , even in 
21 
neurologically normal dogs.60 Brain lesions with RMSF are similar, and consist of a 
necrotizing vasculitis with perivascular and meningeal polymorphonuclear and 
lymphocytic infiltration. 61 In acute cases, meningoencephalitis with vasculitis and 
focal nodular gliosis in the parenchyma can be observed. lmmunohistochemical 
staining on brain tissue for Ehrlichia spp. and Rickettisia rickettsii has not been 
described, nor has immunohistochemical characterization of the inflammatory cell 
populations. 
In conclusion, immunohistochemistry is a useful tool in the differentiation of 
canine CNS inflammatory and infectious diseases. Its use on paraffin embedded 
CNS tissue and CSF may aid in more accurate diagnoses, and in the 
implementation of more useful and accurate therapeutic options and prognostication 
in dogs. 
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Figure 1. 
Figure 2. 
Figure 3. 
Cerebrospinal fluid containing a mixed population of inflammatory cells 
including lymphocytes, macrophages (monocytes) and lesser numbers 
of neutrophils. Antemortem differentiation of canine CNS diseases 
producing this type of inflammation presents a difficult challenge. Bar = 
180 µm 
·• 
Illustration of immunohistochemical staining using the streptavidin-
biotin immunoperoxidase technique. (DAKO LSAB2 HRP systems). 
This technique allows more sensitive visualization of tissue antigens. 
Cerebrospinal fluid sample from a dog diagnosed with granulomatous 
meningoencephalomyelitis (GME). Note the mixed population of 
lymphocytes and monocytes (macrophages) (arrows) with lesser 
numbers of neutrophils. Bar= 14 µm (100 oil mag.) 
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Figure 4. 
Figure 5. 
Figure 6. 
Figure 7. 
Figure 8. 
Figure 9. 
Histopathologic lesion with marked multifocal perivascular infiltrates 
(arrow) and granuloma formation containing lymphocytes, 
macrophages, plasma cells and lesser number of neutrophils in a dog 
with granulomatous meningoencephalomyelitis. Brainstem. HE (6.3X). 
Bar= 100µm. 
·. 
Magnification of Fig . 4 showing marked perivascular infiltration of 
inflammatory cells that extend into the surrounding neuropil. 
Brainstem. HE (16X) Bar= 100 µm. 
Perivascular lesion containing CD3 antigen positive lymphocytes 
(arrow) in the cerebral cortex of a dog with GME. Streptavidin-biotin-
immunoperoxidase technique. Hematoxylin counterstain. 16X Bar= 
100 µm. 
Cerebral cortex perivascular infiltrates containing positive 
immunoreactivity for lysozyme in a dog with GME. Streptavidin-biotin 
immunoperoxidase technique. Hematoxylin counterstain (6.3 x mag.) 
Bar= 100µm. 
Cerebral cortex; canine distemper encephalitis. Diffuse infiltrate of 
lysozyme positive cells. Streptavidin-biotin immunoperoxidase 
technique. Hematoxylin counterstain (16X) Bar= 100 µm. 
Marked perivascular infiltrates in the cerebral cortex of a dog with 
disseminated Toxoplasma gondii. Note the lymphocytes with positive 
reactivity to anticanine lgA, M, and G antigen (arrows). Steptavidin 
biotin immunoperoxidase technique. Hematoxylin counterstain. (16X). 
Bar= 100 µm. 
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CHAPTER 3 IMMUNOHISTOCHEMICAL COMPARISON OF MONONUCLEAR 
CELL POPULATIONS IN DISEASES OF THE CANINE CENTRAL NERVOUS 
SYSTEM 
Abstract 
A paper to be submitted to the journal , Veterinary Pathology 
Karen L. Kline, Claire Andreasen 
A total of 39 dogs with central nervous system (CNS) mononuclear 
pleocytosis , confirmed histologically were characterized immunohistochemically 
using antibodies against CD3, lysozyme, canine immunoglobulin (lgG, lgM, lgA) , 
canine distemper virus, Toxoplasma gondii, and Neospora caninum. Twenty-six 
dogs had lesions compatible with granulomatous meningoencephalomyelitis (GME), 
6 canine distemper virus (CDV), 1 toxoplasmosis, 1 neosporosis, 2 had CNS lesions 
of unknown cause, and 3 had malignant CNS lymphoma involving the spinal cord. 
All dogs were evaluated immunohistochemically for antigens to CDV, Toxoplasma 
gondii and Neospora caninum. Dogs ranged in age from 2 months to 14 years, and 
the ratio of females to males was 2: 1. There was no breed predilection. CNS 
lesions consisted primarily of lymphocytes and macrophages in perivascular and 
granulomatous parenchymal and meningeal infiltrates. Macrophages and 
lymphocytes comprised the majority of the infiltrates, in each disease category. 
Dogs with GME had primarily CD 3 antigen positive T cells, as well as, lysozyme 
positive cells. The distemper subgroup had less numerous cellular infiltrates overall, 
with lysozyme reactivity barely predominating over anti-canine lg reactivity. CD3+ 
33 
reactivity was minimal. The 2 dogs with toxoplasmosis and neosporosis had 
marked lymphocytic perivascular infiltrates that were predominantly 8-cell origin, 
and lysozyme staining was less common, but predominated in the neosporosis 
case. CD 3 antigen-positive T cells were rare in this subgroup. The 2 unclassified 
cases had equal lysozyme, CD 3, and 8 cell staining. The 3 malignant spinal 
lymphoma cases were 8-cell origin. These results demonstrate that: 1) 
subpopulations of mononuclear cells can be determined by assessing antigen 
expression and 2) different populations of mononuclear cells are present in GME, 
CDV, Toxoplasma gondii and Neospora caninum. 
Key Words 
CNS. Canine; Granulomatous meningoencephalomyelitis; Canine Distemper; 
Protozoa! Diseases; lmmunohistochemistry. 
Introduction 
Canine inflammatory and infectious diseases of the CNS have been difficult 
to diagnose and differentiate. The most unique disease is granulomatous 
meningoencephalomyelitis (GME), but others include canine distemper virus (CDV), 
protozoa! diseases such as Toxoplasma gondii and Neospora caninum, and the 
rickettsial agents, Erhlichia canis and Rickettsia rickettsi. Theories surrounding the 
etiology of GME have been numerous, ranging from an immune-mediated to an 
infectious or neoplastic cause, although, none have been proven. s-10•31 ·55·59·61 ·67·69 As 
a result, the term granulomatous meningoencephalomyelitis has primarily been a 
descriptive morphologic term to describe the type of CNS lesions observed 
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histopathologically, or on antemortem diagnostics, such as cerebrospinal fluid (CSF) 
analysis. The difficulty is whether GME encompasses a plethora of CNS 
inflammatory and infectious diseases such as pug encephalitis, necrotizing 
encephalitis of Maltese dogs, necrotizing encephalitis of Yorkshire terriers, 
toxoplasmosis, or neosporosis. 4· 11 -15·26·27·34·37·55·56·59·61 ·66·67 The challenge has been to 
devise more sensitive antemortem and postmortem diagnostic techniques that aid in 
the differentiation of these diseases. On CSF analysis, these diseases are similar 
resulting in a mononuclear pleocytosis with lesser numbers of neutrophils.5·29·59·61 ·64 
Causative agents often are difficult to demonstrate. 
The purpose of this retrospective study was to use immunohistochemical 
techniques2·3·18·19·25·30·31 ·40 to help differentiate and characterize T and B lymphocyte 
and monocyte/macrophage cell populations in perivascular-associated and 
granulomatous cellular infiltrates, to identify infectious causes, and to correlate the 
cell populations to disease etiology. The following disease categories were used: 
GME, canine distemper virus, toxoplasmosis, neosporosis, undefined CNS 
inflammation, and primary CNS lymphoma. The purpose of this study was to 1) 
assess commercially available immunohistochemical methods to differentiate the 
aforementioned diseases, 2) to promote more accurate and beneficial diagnostic 
and treatment protocols, 3) to help define the underlying pathophysiologic 
mechanisms of these diseases (primarily GME), and 4) to serve as a possible 
animal model for human diseases such as multiple sclerosis and subacute 
sclerosing panencephalitis. 6•7•43·44·51 •57• 63· 73 
Materials and Methods 
Animal and tissue processing 
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A retrospective study was done on the brain and spinal cord tissue from 39 
dogs. The study group consisted of 26 dogs with histopathologically confirmed 
granulomatous meningoencephalomyelitis (GME), 6 dogs with canine distemper 
virus (CDV), 1 dog with disseminated toxoplasmosis, 1 dog with disseminated 
neosporosis, 2 dogs with uncharacterized CNS inflammation, and 3 dogs with CNS 
(spinal cord) lymphoma. The spinal cord lymphoma cases were included for 
comparison, since CSF fluid can appear very similar in these CNS diseases. 
Histopathology is usually able to distinguish CNS lymphoma from other 
inflammatory CNS diseases. The medical records of all of the dogs were examined 
and tissue blocks containing brain and spinal cord sections were retrieved. All 
animals had histopathologic evaluation at Iowa State University College of 
Veterinary Medicine. Brain tissues were fixed in 10% non buffered formalin and 
embedded in paraffin. Four µm sections were stained with hematoxylin and eosin for 
histologic assessment and additional sections were used for immunohistochemistry 
(IHC). Brain tissue from one dog with no clinical or histopathologic evidence of CNS 
inflammation was used as a control. 
lmmunohistochemistry 
lmmunohistochemistry was done on 10% neutral buffered formalin-fixed 
paraffin-embedded brain or spinal cord tissue. Tissue sections were 
immunohistochemically stained using a streptavidin-biotin immunoperoxidase 
technique. Rabbit anti-serum against canine immunoglobulins (lgA, lgG and lgM, 
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lmmunovision, diluted 1 :60,000), commercial rabbit antiserum against human T cell 
antigen CD3+ (DAKO, diluted 1:100), and rabbit antiserum against human 
lysozyme (DAKO, diluted 1 :800) were used (Tables 1 and 2). Controls consisted of 
canine jejunum and lymph node for immunoglobulins, canine lymph node for CD3+ 
T-cells, and canine spleen for lysozyme. Slides with 3 µm tissue sections were 
placed in a 57° C oven for at least 30 minutes, then deparaffinized and rehydrated 
by sequential immersion in xylene, graded concentrations of ethanol (100% alcohol, 
95% alcohol, and 70% alcohol), then ultrapure water. Antigen retrieval was 
accomplished either using microwave heating or enzyme digestion (Table 2). For 
the microwave technique, slides were placed in a Coplin jar containing Tris (pH 10) 
and microwaved on full power, then 180 Watts for 5 minutes, slides cooled for 20 
minutes in a -20° C freezer, and transferred to Tris buffer for 5 minutes. For enzyme 
digestion, slides were placed in Tris for 5 minutes at room temperature, transferred 
into a 0.05% protease (Protease, Sigma P5147, Type XIV) solution for 6 minutes at 
room temperature followed by a rinse in Tris for 5 minutes. After the microwave or 
enzyme digestion procedures, slides were blocked with a 10% solution of normal 
goat serum diluted in Tris/PBS/BSA, for 20 minutes at room temperature, incubated 
in a humidified chamber either for 20 minutes at room temperature for CD3 or 
overnight for canine immunoblobulin or lysozyme. Endogenous peroxidase activity 
was blocked using 3% hydrogen peroxide (H20 2) twice for 10 minutes. After rinsing 
with Tris, the slides were then incubated at room temperature for 15 minutes with 
the appropriate biotinylated secondary antibody (Bio Genex's Multilink (HK 268-UK) 
diluted 1 :80 in Tris/PBS/BSA, rinsed, followed by horseradish peroxidase-
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streptavidin (Zymed's HRP-Streptavidin (43-4323) diluted 1 :200 in Tris/PBS/BSA) at 
room temperature for 15 minutes. Slides were rinsed with Tris for 5 minutes, and 
the substrate was then developed with chromagens: 3-amino-9 ethylcarbazole 
(AEC) for CD 3 and lysozyme or Nova Red Substrate Solution for canine 
immunoglobulins. Chromagen development occured over 5 to 20 minutes. Slides 
were then counterstained with 1/4 strength hematoxylin. AEC slides were 
coverslipped using a permanent aqueous mounting medium (Crystal/Mount, · 
Biomedia Corp. cat no. MO3). Nova Red slides, were dehydrated in 95% ethanol, 
absolute ethanol, and cleared with xylene, and coverslipped with a non-aqueous 
mounting media (Acrytol Mounting Medium (Surgipath). 
Toxoplasma qondii IHC 
The sections were cut at 4 microns, mounted on slides, and dried in a 60° C 
oven for 15 minutes. All buffers and trypsin were pre-warmed to 37° C before using. 
Positive and negative controls were Toxoplasma gondii positive and negative feline 
brain tissue, respectively. A microprobe system was used (Fisher Scientific-catalog 
#15-188-20). Briefly, tissues were deparaffinized in xylene or Pro-par for a total of 
10 minutes, rinsed 3 times in alcohol, placed in a 3% H2O2 bath for 5 minutes, then 
rinsed well in deionized water, and placed in a 0.1 % Trypsin bath (50 ml Tris, pH 7 .6 
+ 0.05 gm trypsin) for 30 minutes at 37° C. Then slides were washed in deionized 
water 5 minutes, rinsed in PBS/Tx (0.13 M), and cover plated for 30 minutes at 
room temperature. T. gondii primary antibody (DAKO 1 :3000) was incubated for 2 
hours. Then linking reagent (Dako II) was incubated for 20 minutes at room 
temperature, and then slides were rinsed and the labeling reagent (Dako II) was 
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placed on the slides and incubated 20 minutes at room temperature. Slides were 
counterstained with Gill's Hematoxylin for 10 seconds, washed for 5 minutes, 
dehydrated, and coverslipped. Positive slides contained brown staining of 
trophoblasts, scattered tissue cysts, and tachyzoites. 
Neospora caninum IHC 
Tissues were fixed in 10% neutral buffered formalin, 4 micron sections were 
cut, and mounted on poly-L-lysine-coated slides. Sections were dried in 60° C oven 
for 15 minutes, tissues were deparaffinized twice at 15 minutes, hydrated through 
graded ethanol and deionized water, quenched in 3% H20 2 for 15 minutes, and 
rinsed in deionized water. 0.05% protease (Sigma P-5147) for 2 minutes was used 
for antigen retrieval and then slides were rinsed in Tris/PBS for 5 minutes 5% rabbit 
serum in Tris/PBS was used for blocking. DAKO N. caninum antibody (1:1 dilution) 
was applied for 1 hour at room temperature. Slides were rinsed in Tris/PBS, and a 
secondary DAKO LSAB2 antibody (rabbit antigoat) applied for 10 minutes, slides 
rinsed again in Tris/PBS, a tertiary DAKO LSAB2 antibody was applied for 1 O 
minutes, and the slides rinsed in Tris/PBS. 3,3 diaminobenzidine tetrahydrochloride 
(DAB) (DAKO) was incubated for 5 minutes, and slides rinsed with deionized water. 
Slides were counterstained with Gill's hematoxylin for 10-30 seconds, rinsed, 
dehydrated, cleared and coverslipped. Positive slides contained scattered brown 
chromagen-stained zoites and cysts. 
Canine Distemper Virus-lHC 
Five-µm sections of each tissue block were cut and submitted for CDV 
immunohistochemistry. Sections were mounted on slides coated with 0.1 % poly D-
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lysine stained using an avidin-biotin complex technique adapted for a robotic slide 
stainer using a rabbit polyclonal antisera to measles virus. Two sections of each 
tissue block were stained with 1 :4,000 and 1 :8,000 dilutions of anti-CDV antiserum, 
and the third section was stained with a 1 :4,000 dilution of an unrelated rabbit 
antiserum (negative control). 25 A section of brain tissue from a GOV-infected dog 
was stained at the same time (positive control). lmmunohistochemical staining for 
CDV was graded as either positive or negative. 
Lesion Scoring System 
The quantification of positive immunoreactive mononuclear cells was 
performed using light microscopy and the lesion reaction scoring system used by 
Kipar, et al. 31 The numbers of immunohistochemically reactive cells (CD3+, anti-
canine lg, and lysozyme) were evaluated on each slide as follows: - (0-5% cells; 
negative)+ (6-25% cells, single cells), ++ (26-50% cells, few cells) , +++ (51-75% 
cells moderate number of cells), ++++ (76-100% cells, marked number of cells). A 
minimum of 10 perivascular or granuloma cell infiltrates from each animal were 
evaluated. The magnification used was 10 x. 
Results 
Clinical Presentation (Table 3) 
Granulomatous Meningoencephalomyelitis (GME) (n=26.) 
Dogs ranged in age from 2 months to 14 years. The ratio of females to 
males was approximately 2:1 (Table 3) and there was no breed predilection. 
Neurologic clinical signs were variable and ranged in duration from hours to weeks. 
Acute or chronic forebrain (cerebral) signs, such as behavior changes, seizures, 
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hemianopsia, contralateral partial cranial nerve deficits, proprioceptive loss and 
hemiparesis were observed in 11 cases. Central vestibular signs, such as an 
altered level of consciousness from dullness to coma, head tilt, vertical down beat 
and changing nystagmus, ipsilateral complete cranial nerve deficits, conscious 
proprioceptive loss and paresis, were observed in 3 cases. Cervical, thoracolumbar 
or lumbosacral spinal cord signs, such as spinal hyperpathia, proprioceptive loss 
and ataxia, tetra or paraparesis/plegia, were seen in 6 cases. Six dogs in this group 
presented with multifocal (brain and spinal cord) neurologic deficits. Fourteen dogs 
had cerebrospinal fluid (CSF) analysis performed (Table 3). CSF white blood cell 
(WBC) counts ranged from O to 1600/µI and the percent mononuclear cells ranged 
from < 10% to < 100%. After presentation to the Veterinary Teaching Hospital 
(VTH) 19 cases were euthanized and 7 died upon or shortly after presentation. 
Canine Distemper Virus (n=6) 
Six cases of canine distemper were evaluated. Dogs ranged in age from 4 
weeks to 6 years (Table 3). Neurological signs consisted of behavior changes and 
focal to generalized seizures in 5 dogs, and myoclonus in 1 dog. One dog (case 30) 
exhibited blindness as a presenting complaint. This dog had been vaccinated 10 
days prior to the onset of its clinical signs with a modified-live-5-way vaccine. 
Another dog (case 32), had not been vaccinated since puppyhood (8 weeks of age) 
and had localized right forebrain signs. Five of the 6 dogs were refractory to seizure 
management. CSF analysis was performed on cases 30 and 32 (Table 3). CSF 
WBC counts ranged from 64 to 318 µI, and the percent mononuclear cells ranged 
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from 98% to 100%. In these 2 cases, lymphocytes were the primary cell type. All 6 
dogs were euthanized at the VTH. 
Uncharacterized CNS Disease (n=2) 
These two dogs presented with more protracted, insidious neurologic signs 
than those in the other groups. Dog 33 demonstrated abnormal conscious 
proprioception at the time it presented for an orthopedic evaluation. Signs 
progressed to circling, hypermetria and pawing at the face, consistent with multifocal 
CNS involvement over a period of 10 days. MRI was performed and revealed 
severe, diffuse forebrain edema and no focal lesions. A CSF analysis was within 
normal limits (WSC 4 µI, RSC 75 µI). Dog 34 was the oldest dog (14 years) and 
exhibited progressive left forebrain disease for several months. MRI revealed no 
abnormalities. The CSF was within normal limits (WSC 3µ1, RSC 3350µ1). 
Malignant Spinal Cord Lymphoma (n=3) 
Three dogs presented with neurological signs consistent with extradural 
spinal cord impingement including severe cervical neck and thoracolumbar pain. 
Dog 35 presented with tetraparesis and signs of a left C6-T2 myelopathy. Chest 
radiographs revealed a large thoracic mass, confirmed at necropsy, to invade the 
cervical skeletal musculature and the brachia! plexus. Dog 36 presented with an 
acute onset of hind limb paresis. A myelogram revealed an extradural spinal cord 
compression at L2-L3• The lesion was partially resected at surgery during a 
hemilaminectomy. Dog 37 presented with signs consistent with a T3-L3 myelopathy 
(hind limb paralysis, thoracolumbar hyperpathia and bilateral proprioceptive loss). 
Myelography revealed an L 1-2 extradural compression which was partially debulked 
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surgically during a hemilaminectomy. CSF analyses on both cases 36 and 37 were 
acellular. 
Neosporosis (n=1) 
Dog 38 presented with a progressive history of hind limb weakness of 1 week 
duration. A T3-L3 myelopathy was suspected, and a lumbar CSF analysis and 
myelogram were performed. The myelogram was found to be within normal limits, 
but the CSF analysis had a mixed pleocytosis with 397 leukocytes/µ! and 3 RBC/µI 
(See Table 3). The dog was placed on corticosteroids for a presumptive diagnosis of 
spinal GME (in the absence of observing any infectious agents, negative CSF 
toxoplasmosis and rickettsial titers). Three months later, the dog represented in 
fulminant liver failure and immunohistochemical staining confirmed Neospora 
caninum. 
Toxoplasmosis (n=1) 
Dog 39 presented for a week's duration of progressive circling and falling to 
the right. The dog exhibited multifocal CNS signs and was euthanized by the 
referring veterinarian due to rapid progression of signs. No CSF analysis was 
performed. lmmunohistochemical staining confirmed Toxoplasma gondii. 
Histopathologic Findings 
GME (Figs 1 and 2) 
CNS lesions in this subgroup were multifocal in character and affected, in the 
majority of cases, all areas of the brain (cerebrum, thalamus, brainstem, cerebellum) 
and spinal cord. Specifically, 10 dogs had multifocal lesions involving brain and 
spinal cord; 6 had lesions affecting the brain only; 3 had lesions affecting the 
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cerebral cortex alone, 2 had lesions affecting the spinal cord alone; 2 the cerebral 
cortex and brainstem alone; and one each: the brainstem only; cerebrum and spinal 
cord only; and the brainstem, cerebellum, and spinal cord only. Lesions affected 
both the white matter (predominantly) and grey matter. The most common lesion 
was perivascular infiltrates that varied from mild to severe with aggregates of 
lymphocytes, plasma cells and macrophages. The numbers of lymphocytes, plasma 
cells, and macrophages were variable, but no specific mononuclear cell 
predominated in lesions around the vessels or in Virchow-Robin spaces. The 
perivascular infiltrates extended out to the leptomeninges in 9 cases. Distinct 
granulomas were observed in 7 cases. Other lesions included focal gliosis, (3 
cases) , small foci of malacia (5 cases), neuronal ischemia (1 case) , hemorrhage (3 
cases), evidence of foramen magnum herniation (2 cases), hydrocephalus (4 
cases), cavitation (2 cases), demyelination (1 case) and axonal swelling (1 case) . 
One case with spinal cord involvement (multifocal), showed an infiltrate of plump, 
round to spindle-shaped cells with an abundant foamy cytoplasm and 1 mitotic 
figure/per high-power field. 
Canine Distemper Virus (Fig. 3) 
Of the six cases observed , 4 had multifocal lesions in the brain only, 1 had 
multifocal lesions in the brain and spinal cord, and 1 had lesions in the brainstem 
and cerebellum only. Lesions in these 6 cases were mild, multi-focal, and 
occasionally coalescing with perivascular infiltrates of equal numbers of lymphocytes 
and plasma cells, with lesser numbers of macrophages, primarily involving the white 
matter neuropil , and less often the leptomeninges. White matter lesions included 
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the anterior medullary velum, the cerebellar folia , and the cerebellar peduncles. In 
addition , focal areas of mild to severe demyelination, dilated axonal sheaths, and 
gliosis were observed (cases 27-30 and 32) . The six cases had intranuclear (case 
27 and 28) and intracytoplasmic ( cases 29-32) inclusion bodies. 
Uncharacterized CNS Diseases 
Both cases were unusual in that the histopathologic lesions were vastly 
different from the other cases. Case 33 contained severe, multifocal malacia of the 
cortical white matter with large areas of dilated axonal sheaths, and neuropil 
degeneration, described as primary demyelination. In addition, focal accumulations 
of glial cells and perivascular infiltrates composed primarily of lymphocytes, were 
found in the white matter (Fig. 4). There also was moderate multifocal lymphocytic 
and plasma cell infiltration of the leptomeninges. Case 34 had predominately white 
matter vacuolation in the neuropil unaccompanied by glial changes, as well as 
astrocyte hypertrophy described as spongiform myelinopathy. 
Malignant Spinal Cord Lymphoma 
Cases 35-37 had characteristic lesions of spinal lymphoma; one cervical 
(case 35) and the other 2 thoracolumbar (cases 36 and 37). In each case, the 
extradural mass was composed of sheets of round cells with with irregular ovoid to 
slightly cleaved nuclei with prominent nucleoi (lymphoblasts). The mitotic index 
ranged from low (case 36) to high (cases 35 and 37). 
Neosporosis (Fig. 5) 
Case 38 had a moderate to severe meningeal infiltrate of lymphocytes and 
macrophages with smaller foci of neutrophils and macrophages in the neuropil, 
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especially in those areas associated with organisms. Within the neuropil, dilated 
axonal sheaths and necrosis were observed associated with macrophages. 
Although these lesions diffusely involved the brain, the brainstem was most severely 
affected . White matter vacuolation was observed in the spinal cord. 
T oxoplasmosis (Fig. 6) 
In case 39, both the brain and spinal cord had multifocal lesions. The 
cerebral cortex and brainstem had a mononuclear meningeal infiltration consisting 
of lymphocytes, plasma cells, and macrophages. The brain parenchyma contained 
zones of nodular to diffuse gliosis, thick perivascular areas of mononucle.ar 
inflammatory cells, and foci of malacia in which occasional neurons contained 
protozoa! tachyzoites or rosettes. In the spinal cord, there were multiple foci of 
perivascular inflammation , gliosis, and malacia. 
lmmunohistochemistry 
Negative control brain and spinal cord tissue revealed no T, B cell or 
lysozyme activity. In addition, stains for canine distemper virus, T. gondii and N. 
caninum were all negative in control tissue. lmmunohistochemical findings will be 
discussed according to disease category. 
Granulomatous Meningoencephalomyelitis (GME) 
Twenty-five GME cases had a majority of anti-canine lgG, lgM and lgA 
reactive cells in the perivascular regions (Fig. 7). Lesser numbers of positive cells 
were in parenchymal granulomas. Perivascular infiltrates were present in 20 cases 
and classified as: few(++, 26-50%) in 13 cases and moderate(+++, 51-75%) in 7 
cases. Cases 1, 3, 14, and 17 had single positive(+, 6-25%) cells. No marked 
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{ ++++, 76-100%) cellular infiltrates were observed. Case 11 was negative. Anti-
canine lg reactivity in granulomas was few(++, 26-50%) in 9 cases, moderate(+++, 
51-75%) in 5 cases, marked(++++, 76-100%) in 2 cases, single(+, 6-25%) in 3 
cases, and negative(-, 0-5%) in 6 cases. 
In 26 GME cases, there was a more even distribution of CD3+ T-cells (Fig. 9) 
between perivascular infiltrates and granulomas. Marked(++++, 76-100%) T cell 
numbers were observed in 5 cases, moderate(+++, 51-75%) in 15 cases, few(++, 
26-50%) in 4 cases, and single(+, 6-25%) in 2 cases. Granulomas containing T 
cells were classified as: marked ( ++++, 76-100%) in 1 case, moderate ( +++, 51-
75%) in 16 cases, few(++, 26-50%) in 5 cases, and negative in 4 cases. 
Perivascular infiltrates and granulomas had immunoreactivity for lysozyme 
(Fig 12). Perivascular infiltrates had marked reactivity(++++, 76-100%) in 3 cases, 
moderate(+++, 51-75%) in 10 cases, few(++, 26-50%) in 10 cases, single(+, 6-
25%) in 1 case, and negative(-, 0%) in 2 cases. Lysozyme reactivity within 
granulomas ranged from marked(++++, 76-100%) in 3 cases, moderate(+++, 51-
75%) in 9 cases, few(++, 26-50%) in 9 cases, and negative in 5 cases. All 26 dogs 
had negative reactivity for Toxoplasma gondii, Neospora caninum and canine 
distemper IHC results. 
Canine Distemper Virus 
Of the 6 dogs with CDV evaluated for anti-canine lgM, lgG, and lgA reactivity, 
the majority (all 6) demonstrated positive staining in perivascular areas. Few 
granulomatous lesions were observed. None of the perivascular infiltrates showed 
marked reactivity, 2 showed moderate numbers of cells(+++, 51-75%), and 4 
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demonstrated few cells(++, 26-50%). Case 30 demonstrated a more pronounced 
granulomatous infiltrate with, few reactive cells (++,26-50%). The remaining 4 cases 
were negative. T cell CD3 reactivity in the CDV dogs was minimal, both 
perivascularly and in granulomas. Cases 27 and 32 had single(+, 6-25%) T cell 
infiltrates perivascularly, while case 28 was moderate(+++, 51-75%). The 
remaining cases were negative. Case 28 was the only one with T cell positive 
staining within a granulomatous region that was moderate(+++, 51-75%). No other 
granulomatous regions (though minimal in numbers) had T cell reactivity. 
Lysozyme staining in CDV dogs was predominantly perivascular. Moderate 
cell numbers(+++, 51-75%) were observed in 3 cases (Cases 27-29) (Fig . 11) and 
few(++, 26-50%) in 2 cases (Case 30 and 32). Case 31 was negative. 
Granulomatous infiltrates were rare, and only one case (case 29) had moderate 
(+++, 51 -75%) reactivity. IHC for Toxoplasma gondii and Neospora caninum was 
negative in all 6 dogs. Of these 6 dogs, four had a positive CDV IHC in CNS 
tissues. 
Uncharacterized CNS Cases 
The 2 unclassified cases (cases 33 and 34) had variable results. Case 33 
showed moderate(+++, 51-75%) perivascular anti-canine lg reactivity, with negative 
granuloma reactivity. Case 34 had few reactive cells(++, 26-50%) in perivascular 
and granulomatous areas. Perivascular T cell reactivity in both cases was few cells 
(++, 26-50%). Lysozyme reactivity was perivascular only and ranged from few cells 
(++, 26-50%) in case 33 to single cells(+, 6-25%) in case 34. No granulomas were 
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observed. Both cases were IHC negative for Neospora caninum, Toxoplasma 
gondii, and CDV antigen. 
Malignant Spinal Cord Lymphoma 
The 3 spinal lymphoma cases were confirmed as B cell in origin. All had 
negative IHC for Toxoplasma gondii, Neospora caninum and CDV antigen. 
Neosporosis 
Case 38 had immunoglobulin reactivity both perivascularly (+++, 51-75%) 
with moderate numbers of cells and in numerous granulomas (+++, 51-75%). T cell 
reactivity was negative or absent, both perivascularly and within granulomas. 
Lysozyme reactivity was moderate(+++, 51-75%) both perivascularly and within 
granulomas (Fig. 10). IHC for Toxoplasma gondii and CDV antigen was negative. 
Toxoplasmosis 
Toxoplasmosis (case 39), had moderate(+++, 51-75%) canine anti-lg 
reactivity both perivascularly (+++, 51-75%) and within granulomas (+++, 51-75%) 
(Fig. 8). T cell reactivity was minimal(+, 6-25% cells) both perivascularly (17%) and 
within granulomas (6%). Lysozyme reactivity was minimal perivascularly (+, 21%) 
and was negative in granulomatous lesions. IHC was negative for Neospora 
caninum and CDV antigen. A summary of the immunohistochemical findings is 
presented (See Figs. 13, 14). 
Discussion 
The inflammatory cell populations of dogs with histopathologically confirmed 
GME (granulomatous meningoencephalomyelitis), canine distemper virus (CDV), 
toxoplasmosis, and neosporosis, were characterized by immunohistochemistry. 
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Two other cases of unknown CNS inflammation and 3 cases of spinal cord 
lymphoma als0 were characterized. 
Granulomatous Meningoencephalomyelitis (GME) 
The lesions observed histopathologically in 26 dogs with GME were 
consistent with those described in the literature.5·8•10·29·31 ·42·55·59·61 ·64·67·69 GME has a 
definite tropism not only for the brain parenchyma, but for the vessels that nourish 
the parenchyma and meninges, leading to a breakdown in the protective blood-brain 
barrier. Only a few studies have immunohistochemically characterized the lesions 
and cellular infiltrates seen with GME.31 ·64·69 The distributions of mononuclear cells 
were consistent with those reported in the literature, but there were some distinct 
differences. 
In the 26 dogs with GME, (CD3+) Tcell staining was observed most often in 
both perivascular infiltrates and granulomas. This was followed by lysozyme and 
then anti-canine lg in lesser numbers. The presence of CD3 positive T cells in GME 
has been associated with a possible T cell-mediated delayed-type hypersensitivity 
autoimmune dysfunction.31 The results of this study indicate this theory may be 
correct, based upon the high representation of CD3 positive T cells. Further 
research is still necessary to elucidate the sub-components involved in the possible 
immune-related dysfunction, i.e. specific cytokines, and other T-cell subpopulations 
such as CD4+, COB+ cells. Several studies have suggested that GME is initiated by 
an underlying infectious mechanism (bacterial, viral, protozoa! agents) that 
stimulates an aberrant immune-mediated inappropriate T cell response like the 
response seen in multiple sclerosis_s.s,-10,31,42,ss,ss,s1,s4,s1,es 
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The second most observed antigen in GME was lysozyme. Lysozyme has 
been used as an immunohistochemical marker of histiocytic and 
monocytic/macrophage differentiation in human proliferative and granulomatous 
disorders40 and also has been used to study canine GME.31 ·69 It is a marker for 
monocytes, tissue macrophages, and their precursors; the percentage of positive 
cells increases with maturation.40 Some studies suggest that lysozyme may be a 
marker for recent blood-derived macrophages.40 The presence of lysozyme positive 
cells in GME perivascular infiltrates and granulomas may help support theories of 
hematogeneous and temporal origin, respectively. These cells can potentially be 
observed with more chronic, ongoing lesions. 
Anti-canine lg reactivity although less than CD3 and lysozyme reactivity was 
observed more than in other previous studies.31 ·69 The granulomas observed in 
GME had more lg reactivity than perivascular infiltrates. The significance of this 
finding has to be determined and may be limited to this subpopulation of 26 cases. 
It is interesting to note the lesions and cell populations did not change in spite of 
treatment with anti-inflammatory drugs, such as corticosteroids. The significance of 
altered or lack of altered cell populations, due to treatment, is currently unknown. 
Of the 26 GME cases, none were determined to be neoplastic origin. One 
study of primary reticulosis of the canine brain indicated a possible reclassification 
of reticulosis to primary histiocytic lymphosarcoma, in a small number of cases.69 In 
our study, there was less convincing evidence of neoplasia based upon the 
immunohistochemical results since the cell populations were mixed in origin. 
Canine Distemper Virus 
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The six dogs observed with GOV-related histopathologic lesions had 
immunohistochemical staining that differed from dogs with GME. Overall, there 
were less perivascular and granulomatous cellular infiltrates than the predominantly 
perivascular lesions discussed in the literature. 1·16·22•24·28· 33·48·50·53·60•52, 64·67·74 In all but 
two cases, granulomatous lesions were not observed. Lysozyme reactivity 
predominated when compared to CD3 and anti-canine lg reactivity. One possible 
explanation of this would be due to the time course of infection and cellular 
maturation ; although, some studies have identified diffuse macrophage infiltration in 
the later stages of C0V. 60 No studies on CDV have looked at lysozyme reactivity 
and 3 cases had prominent perivascular reactivity. It appears that immunoglobulins 
play a minimal role in the pathogenesis68 and reactivity in CDV was minimal. One 
case demonstrated moderate perivascular lg reactivity. T cell (CD3) reactivity also 
was minimal. This finding differs from other studies that describe CD3+ expression 
as being a key feature of CDV, dependent upon the time of infection and its clinical 
course. Many reports in the literature describe a definite temporal relationship in 
canine distemper as to type, extent and severity of lesions observed. 1·28·33·48·58•65·70•72 
Acute demyelination is thought to occur first with the absence of cellular infiltrates 
due to a period of severe immunosuppression in the absence of inflammatory 
changes. This is followed by the subacute phase characterized by continued 
demyelination accompanied by reactive changes, including astrocyte and microglial 
proliferation, with moderate mononuclear perivascular infiltration. The chronic 
phase follows which is characterized by thick mononuclear perivascular infiltrates (in 
one study, 60% CD3+, 40% B cells) and a severe vacuolated appearance in the 
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white matter (severe demyelination).65 Inclusion bodies may be seen in 80% of 
these lesions.69 Finally, the sclerotic phase may be observed which is composed of 
well-delineated marked myelin loss, astroglial proliferation, perivascular infiltrates 
(50% of cases), and very few viral inclusions. lmmunohistochemical identification of 
CDV antigen is quite prominent in the acute and subacute phases, but is much less 
evident in the chronic and sclerotic phases. The early demyelinating stage in acute 
lesions has been theorized to be due to direct virus-induced oligodendioglial 
changes. One study describes a diffuse up-regulation of T-cells and diffuse T-cell 
invasion in the acute demyelinating lesions near sites of viral replication due to 
activation of microglia and secretion of chemokines, such as IL8.65 Cytokines also 
have been theorized as promoting mononuclear (lymphocyte and macrophage) 
chemotaxis, which in the more chronic stages, can lead to further cytokine release, 
demyelination and white matter necrosis.23 Some authors view this as an important 
role of the humoral immune system in the pathogenesis of CDV and called the 
"bystander effect". 39·69 Theories about the acute demyelinating lesions in CDV 
infection are numerous.and include a direct interaction of CDV with oligodendroglial 
cells, followed by T cell invasion. This is not thought to be a direct consequence of 
apoptosis or necrosis, but may be directly due to viral-induced metabolic dysfunction 
of oligodendiocytes or supporting cells in the acute phase of illness.52·58·65 Others 
theorize a down-regulation of myelin gene transcription in the oligodendrogliocyte 
that leads to decreased specific enzyme activity. 75 The chronic stage is thought to 
occur due to more profound immunologic complications, although active studies are 
still ongoing.71 ·72 Another theory states, during chronic CDV infection, microglia and 
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astrocytes up-regulate class II MHC expression through cytokines secreted by 
infiltrating T cells and macrophages. This has been described as an 
"epiphenomenon" resulting from mononuclear cell infiltration of the CNS or a direct 
effect of CDV on infected neural cells, since there is limited expression of class II 
MHC in acute or subacute CDV cases. 1 
Due to the minimal inflammatory changes observed in the 6 dogs with CDV, it 
is possible that the temporal theory behind the inflammatory and demyelinating 
lesions observed in CDV may be justified. These dogs may die in the more acute 
phase of CDV infection and have less profound perivascular and granulomatous 
infiltrates, but still have variable degrees of demyelination. Only one case (28) had 
moderate CD3+ expression both perivascularly and in granulomas. It is possible that 
this dog had a more subacute to chronic disease course. All dogs had a few cells 
(++, 26-50%) expressing anti-canine lg perivascularly which differs from the 
literature, since B-cells were found in more subacute to chronic lesions, and tended 
to be associated with CD3+ positive cells.72 Perivascular lysozyme reactivity was 
moderate in 3 cases, and in one case (29), was moderate in granulomas. This is 
somewhat intriguing since lysozyme reactivity is associated with cellular maturation 
and macrophage lineage often reflecting the chronicity of a lesion. Macrophage 
infiltration is associated with chronic CDV. Further studies will need to be conducted 
on other CDV cases to observe if this is a significant finding or trend. In the one dog 
thought to have post-vaccinal distemper, T-cell (CD3 +) reactivity was negative, 
lysozyme reactivity was few(++) perivascular cells, and canine anti-lg was(++) both 
perivascular and in granulomas. In one study, grey matter involvement was thought 
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to be more prevalent in post-vaccinal CDV.47 In this study, lesions were most 
prominent in the cerebral cortex and brainstem consisting of neuronal necrosis and 
mononuclear perivascular infiltrates with an occasional neuronal intranuclear 
inclusion. 
Uncharacterized CNS Cases 
The 2 dogs with uncharacterized inflammation were negative on IHC for 
canine distemper virus, Toxoplasma gondii and Neospora caninum. It is known that 
CDV IHC is less reliable in lesions of chronic CDV and antigen can be undetected. 
Case 33 had both moderate perivascular infiltrates and primary demyelination, but 
was negative on CDV IHC in a well-vaccinated dog. Anti-canine lg, T cell CD3, and 
lysozyme expression was(++, 26-50%) to(+++, 51-75%). Anti-canine lg expression 
was exclusively perivascular. In light of the negative CDV IHC, this could be 
subacute to chronic CDV, although no viral inclusions were found. Case 34 had 
mild inflammatory changes, and had profound white matter vacuolation and 
astrocyte hypertrophy. Any similarities to GME or CDV in the literature are vague at 
best, although this case may fit best with the Type 4 (sclerotic) lesions of CDV.69 
Malignant Spinal Cord Lymphoma 
The 3 spinal lymphoma cases supported the literature in regard to the 
frequency of B cell over T cell related neural lymphoma. 19·20·54 B cell tumors are far 
more common. 
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Toxoplasmosis/Neosporosis 
No reports have identified the immunohistologic characteristics of the 
mononuclear cell populations of toxoplasmosis and neosporosis. Outcomes of 
immunohistochemical staining for Toxoplasma gondii and Neospora caninum 
organisms have been described in the literature.12-14·26·27 There were differences 
between the cell populations in the 2 cases. In Case 38 (neosporosis), canine anti-
lg and lysozyme reactivity were moderate(+++, 51-76%), and no CD3+ lymphocytes 
were identified. Since only one case was examined, it is difficult to make any 
conclusions. In contrast, Case 39 (toxoplasmosis) had moderate expression of anti-
canine lg and minimal(+, 6-25%) to no CD3+ or lysozyme reactivity. In case 38, 
perivascular infiltrates and granulomatous mononuclear infiltrates were equally 
represented and marked in number. The disproportionate cell types observed in 
both cases could be due to enhanced humeral immunity (anti-canine lg, Case 39), 
and chronicity of the inflammatory process, (lysozyme, Case 38). The absence of T 
cells differs from cases of GME and CDV cited in the literature. In this one case, it 
would appear that cell-mediated immunologic mechanisms play a lesser role in the 
pathogenesis of these protozoa! diseases. Macrophages may, in this case, be 
involved in cytokine and inflammatory mediator release. More studies should be 
conducted to determine the roles of Class II MHC, astrocytes and microglia, as well 
as other immune cells. Case 39 had both perivascular and granulomatous infiltrates 
that could play a role in the pathogenesis of toxoplasmosis through humeral 
mechanisms. 
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The dogs with GME had a population of CD3+ cells that predominated, 
possibly inciting an immune response that is primarily cell-mediated. The 6 dogs 
with canine distemper in this study had more lysozyme and anticanine lg reactivity 
with less profound perivascular infiltrates and granulomas. The significance of the 
lysozyme production has yet to be determined, but may be due to microglial 
chemotaxis in the early stages of infection. Five of the 6 dogs with CDV 
demonstrated minimal cellular infiltrates that were consistent with acute infection at 
the time of necropsy with the accompanying demyelination, but had little CD3+ 
expression. It would be helpful to document CD4+ and CD8+ expression in these 
cases to further evaluate the role of T lymphocytes in the pathogenesis of acute 
CDV. From our study, timing of euthanasia of these dogs probably had an effect on 
the lesions observed. 
The 2 uncharacterized cases showed lesions that were consistent with 
chronic to sclerotic CDV infection, but this cannot be proven due to the absence of 
inclusion bodies and demonstratable CDV antigen on immunohistochemistry, and 
low co3+ expression. These cases bear little resemblance immunohistochemically 
to cases in our study with GME that were predominantly CD3+. 
The 2 dogs with neospora and toxoplasmosis had different 
immunohistochemical findings when compared, although each are protozoans. The 
key feature of each is enhanced B cell reactivity with minimal to no T cell reactivity. 
Lysozyme reactivity was marked in the case with neosporosis versus toxoplasmosis. 
The role of tiumoral immunity in cases of neosporosis and toxoplasmosis should be 
evaluated more thoroughly to understand the pathogenesis. 
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In conclusion, this study demonstrates that immunohistochemistry is useful in 
distingu.ishing the cell populations in dogs with GME, canine distemper virus, 
Neospora caninum, Toxoplasma gondii, and malignant spinal cord lymphoma. This 
study may stimulate further evaluation of these diseases immunohistochemically 
using different antibodies, and allow a potential way to differentiate these diseases 
antemortem using immunocytochemical techniques on CSF. Also, this study may 
result in an enhanced ability to utilize appropriate therapies and afford better 
prognostication . 
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Table 1. lmmunohistochemical markers for the characterization of canine 
lymphocytes and macrophages 
Antibody Cell Specificity Source 
Polyclonal Antibodies 
(Rabbit-anti-) 
Human CD3 T cells DAKO 
Dog lgG, lgM, lgA B cells, plasma cells lmmunovision 
Whole Moleculres 
Human Lysozyme Monocytes/Macrophages DAKO 
Granulocytes 
Toxoplasma gondii Toxoplasma gondii DAKO 
Neospora Neospora caninum DAKO 
Canine Distemper CDV Antigen Prairie Diagnostics 
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Table 2. Antibodies and their dilutions used for the streptavidin-biotin 
immunoperoxidase technique 
Antibody Ab Dilution Antigen retrieval 
Polyclonal Primary 
(Rabbit - Anti) Secondary 
Human CD3 1° DAKO T cell, 1:100, 20 min RT 0.05% Protease 
CD3 1 :80, 15 min RT 
2° Biogenex 
Multilink 
Dog lgG, A and M 1 ° lmmunoglobulins 1 :60,000 overnight microwave 
(G,M,A,H,&L) 
2° Biogenex 1 :80, 15 min RT 
Multilink 
Human Lysozyme 1° Lysozyme 1 :800, overnight microwave 
(Muramidase) 1:80, 15 min RT 
2° Biogenex 
Multilink 
Toxoplasma 1° DAKO Toxo 1 :3000, 2 hours 0.1 % Trypsin 
2° Linking agents 1 :200, 20 min, RT 
(DAKO II) 1 :200, 20 min, RT 
3° Labeling agent 
(DAKO II) 
Neospora 1 ° Neospora DAKO 1 :1 1 hour 0.05% Protease 
(Monoclonal) 2° DAKO LSAB2 1 :200, 10 min RT 
3° DAKO LSAB2 1 :200, 10 min RT 
Canine Distemper 1° CDV 1 :4000, 1 :8000 Protease XIV, 
2°Biotinlytated Goat 1:400 (Sigma) 
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Figure 1 
Figure 2 
Figure 3 
Figure 4. 
Figure 5. 
Figure 6. 
Brainstem; Case No. 23 Perivascular (arrow) and granulomatous 
(arrow) infiltrates composed of lymphocytes and macrophages with 
lesser numbers of neutrophils in a dog. HE. 6.3X Bar= 100 µm. 
Brainstem; Case No. 23. Magnification of the perivascular infiltrate 
composed of lymphocytes, macrophages and lesser numbers of 
neutrophils in a dog with GME. HE 16X. Bar= 100 µm. 
Cerebral Cortex; Case No. 28. Severe white matter demyelination and 
dilated axon sheaths that are empty (arrow) in a dog with canine 
distemper encephalitis. HE 16X. Bar= 100 µm. 
Cerebral Cortex; Case No. 33. Severely dilated axon sheaths that are 
empty, lymphocytic perivascular infiltrates, and demyelination in a dog 
with uncharacterized CNS disease. HE 16X. Bar = 100 µm. 
Cerebral cortex; Case No. 38. Dilated axon sheaths that are empty 
and perivascular infiltrates composed of lymphocytes, mac"rophages, 
and neutrophils in a dog with disseminated neosporosis. HE 16X. Bar 
= 100 µm. 
Cerebral cortex; Case No. 39. Perivascular infiltrate composed of 
lymphocytes, macrophages and neutrophils in a dog with Toxoplasma 
encephalitis. HE 16X. Bar= 100 µm. 
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Figure 7. Brainstem; GME. Case No. 24. Perivascular infiltrates with 
lymphocytes staining positive for anti-canine lgG, M, A Streptavidin-
biotin, immunoperoxidase technique. Hematoxylin counterstain. 16 X 
Bar= 100 µm. 
Figure 8. Cerebrum; Toxoplasma encephalitis , Case No. 39. Perivascular 
infiltrate comprised of positive anti-canine lg, Mand A staining 
lymphocytes. Streptavidin-biotin immunoperoxidase technique. 
Hematoxylin counterstain 16 X Bar = 100 µm. 
Figure 9. Cerebral cortex; GME; Case No. 25. Perivascular infiltrate with CD3+ 
staining lymphocytes (arrow). Streptavidin-biotin immunoperoxidase 
technique. Hematoxylin counterstain. 16X Bar= 100 µm. 
Figure 10. Cerebral cortex; Neosporosis, Case No. 38. Granulomatous and 
perivascular macrophages with positive lysozyme staining. 
Streptavidin-biotin immunoperoxidase technique. Hematoxylin 
counterstain. 16X Bar = 100 µm. 
Figure 11 . Cerebral cortex; canine distemper encephalitis. Case No. 28. Diffuse 
infiltrate of lysozyme positive macrophages. Streptavidin-biotin 
immunoperoxidase technique. Hematoxylin counterstain . 16X Bar = 
100 µm. 
Figure 12. Brainstem; GME Case No. 23. Perivascular cuff and granulomas 
comprised of lysozyme positive macrophages. Streptavidin-biotin 
immunoperoxidase technique. Hematoxylin counterstain. 16 X Bar= 
100 µm. 
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Figure 13. Absolute numbers of dogs per category with B cell (Anti-canine lgG, A 
and M), T cell (CD3) and lysozyme staining in perivascular infiltrates 
and granulomas using Kipar's Lesion scoring method.31 
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Figure 14 Percentage of dogs per category showing B cell (Anti-canine lgG, A 
and M), T cell (CD3) and Lysozyme staining in perivascular infiltrates 
and granulomas using Kipar's lesion scoring method. 31 
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CHAPTER 4. GENERAL CONCLUSIONS 
This study used immunohistochemistry to identify CNS cell populations in 
inflammatory diseases that produce a mononuclear pleocytosis in CSF. These 
findings were compared to those animals who had CNS spinal lymphoma and 
uncharacterized CNS disease. Inflammatory diseases included GME, canine 
distemper virus, toxoplasmosis and neosporosis. Antemortem differentiation of 
these diseases can be difficult and can make treatment choices and prognostication 
difficult. This study does support the utility of immunohistochemical techniques to 
differentiate CNS inflammatory diseases. The antibodies used were anti-human 
CD3+, anti-dog lgG, M, and lgA, and anti-human lysozyme. 
The 26 dogs with GME had CD3+ reactivity most often in perivascular 
infiltrates and granulomas, followed by lysozyme reactivity. The results correlate 
with other studies on the immunohistochemical characterization of GME and may 
help to define the role of a T cell-mediated delayed-type hypersensitivity of a brain-
specific autoimmune disease.2·9 Evaluation of other T cell subpopulations such as 
CD4+ and CDS+, as well as, the role of inflammatory mediators, such as the 
cytokines, may aid in the discovery of new treatment protocols, such as 
immunomodulators, that are currently being investigated in the treatment of multiple 
sclerosis. Lysozyme reactivity in our study correlated with that observed in the 
literature, although MHC Class II staining was not done.31·69 These findings suggest 
that activated macrophages (MCH II positive), may play a role in antigen 
preservation and processing. IHC for CDV, toxoplasmosis and neosporosis in 26 
GME cases were negative. No causative agent has been documented in GME. It is 
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known that the cell-mediated immune-response in this disease leads to devastating 
effects in the CNS and can be refractory to current drug treatments, such as 
corticosteroids. Other immunosuppressive agents and immunomodulators such as 
Azathioprine (lmuran®), Cyclophosphamide (Cytoxan®), Cyclosporin and Interferon 
may be of benefit. 
The 6 dogs diagnosed with canine distemper had findings on 
immunohistochemistry that were different from dogs with GME and dogs in the 
literature with CDV. 1· 3· 5-7, 9· 11 · 12 The inflammatory changes, both perivascular and 
granuloma, were minimal in all cases. Granulomas were rare, and CD3+, lysozyme 
and canine lg reactivity varied, with moderate lysozyme reactivity in 3 cases and 
moderate canine lg reactivity in 2 cases. Demyelination was present in all dogs on 
histopathology. In one case, T cell reactivity was moderate and was perivascular. 
Inflammatory changes were minimal in the five of the 6 cases studied, although 
demyelination was already occurring. Literature on neurologic CDV cites that in the 
acute phases of CDV infection, minimal perivascular cell infiltrates occur and 
demyelination is due to a direct viral effect (marked down-regulation of myelination 
on the oligodendiocyte's supporting cells). 4· 5· 10-12•13 As the disease progresses 
through the subacute, chronic, and sclerosing stages, perivascular infiltrates 
becomes more prominent. Some studies indicate the acute stages have minimal to 
moderate up-regulation of T cells due to the release of chemokines, such as IL8 
from the neuroglial cells. MHC II expression on microglial cells, in chronic lesions, is 
prominent and more evident than in the acute stages. An explanation for the 
paucity of CD3+ cells in our study could have been due to the time course of 
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infection. Other studies suggest that CDS+ lymphocytes are more prominent in the 
acute/subacute lesions, and CD4+ cells are more common in the subacute to 
chronic lesions. The CDS+ cells are theorized to function as cytoxic effector cells, 
and the CD4+ cells are thought to initiate a delayed-type hypersensitivity reaction. 
The presence of moderate numbers of canine lg reactivity in 2 cases differs from 
another study that correlates B cell expression with more chronic lesions. Further 
immunohistochemical evaluation of CDV lesions on a temporal basis will need to be 
done to determine if cell populations differ over the disease course. 
The 2 uncharacterized cases had severe demyelination (case 33) and 
vacuolation (Case 34), with no evidence of CDV antigen, Neospora caninum or 
Toxoplasma gondii. Inflammatory cells were minimal and in 1 case (33), were 
perivascular with canine lg reactivity. Whether or not these two animals had CDV 
cannot be differentiated by immunohistochemical results, since in more chronic 
lesions, IHC for CDV antigen is less reliable. Also, in chronic or sclerotic cases, 
inclusion bodies are rarely detected. The demyelinating lesions observed were 
quite striking and were similar to those observed in dogs with chronic and sclerosing 
CDV infection.4· 5 
The 2 dogs with neosporosis and toxoplasmosis had immunohistochemical 
results that were different from those dogs with GME and CDV. Canine lg and 
lysozyme reactivity were moderate in neosporosis, while CD3+ reactivity was 
negative. Canine lg reactivity was moderate in the dog with toxoplasmosis, while 
CD3+ and lysozyme reactivity was minimal. It is possible that humeral immunity 
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may play a more important role in the pathogenesis of protozoa! diseases than cell-
mediated immunity, although, a larger number of cases would need to be studied. 
This study has identified the immunohistochemical characteristics of canine 
CNS diseases that produce a mononuclear pleocytosis in CSF. There are 
similarities between these diseases immunohistochemically, but enough differences 
exist that further study of these diseases and their immunohistochemical properties 
is warranted. A continuation of this study would entail the immunocytochemical 
analysis of the cerebrospinal fluid (CSF) saved from the aforementioned patients 
compared to healthy dogs, in an attempt to correlate antemortem with postmortem 
disease processes. In addition, titers on CSF samples for CDV, Toxoplasma gondii, 
and Neospora caninum can be submitted to determine whether or not these findings 
correlate with the immunohistochemical and cytochemical findings. Other diagnostic 
tools such as polymerase chain reaction (PCR) are currently being validated to 
make the diagnosis of infectious agents more accurate. In addition, further research 
into these diseases is warranted since their pathogeneses are very similar to and 
can serve as animal models for such human inflammatory CNS disorders as 
multiple sclerosis, subacute sclerosing panencephalitis, and Lyme borreliosis. 
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